2026-10-13T22:37:26Z https://data.mendeley.com/oai

oai:data.mendeley.com/hwyb248mkj.2 2022-10-14T18:11:57Z

Hu, Kun Successful experience of secukinumab and ixekizumab in treating erythrodermic psoriasis: A single-center, retrospective study Mendeley Data Erythrodermic psoriasis (EP) is a rare, severe, potentially life-threatening form of psoriasis. Laboratory results may present abnormalities such as leukocytosis, serum albumin loss, and elevated C-reactive protein. The assessment for laboratory data is lacking. This is a retrospective study of 28 cases of EP treated with secukinumab and ixekizumab. Except for skin restoration, initial management should include a full assessment, including an evaluation for systemic inflammation and correction of protein. The sustainability of inflammatory markers over 6 months are presented. Psoriasis Dataset doi:10.17632/hwyb248mkj.2 oai:data.mendeley.com/hwyb248mkj.2 Creative Commons Attribution 4.0 International http://creativecommons.org/licenses/by/4.0 https://data.mendeley.com/datasets/hwyb248mkj 2022-10-14T18:11:57Z